- Loss of Smell More Common in COVID-19 Than Thought
- Psoriasis Meds Don’t Raise Risk of Severe COVID-19: Study
- Diet Drinks Don’t Do Your Heart Any Favors
- Lockdowns Can Widen Kids’ Waistlines – Here’s How to Curb That
- Trial of Antibody Drug for COVID-19 Stopped for Lack of Effectivenes
- Health Highlights: Oct. 27, 2020
- Kidney Trouble Greatly Raises Odds for Fatal COVID-19
- MRIs Might Be Safe for Patients With Implanted Heart Devices
- More Evidence Masks Slow COVID’s Spread
- Dangerous COVID-19 Syndrome First Seen in Kids Also Strikes Adults
Clinical Trials Update: April 30, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Asthma
This study will evaluate an investigational medication for asthma. Candidates must be aged 18 to 60, have asthma, and must not smoke.
The research site is in Baltimore, Md.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/asthma.aspx.
—–
High Cholesterol
This study will evaluate whether an approved medication combined with an investigational drug can reduce plaque build-up in the arteries. You may qualify if you have high cholesterol, are taking a cholesterol medication, or have a history of heart disease.
The research site is in Denver, Colo.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/high_cholesterol.aspx.
—–
Acid Reflux / GERD
This study will evaluate an investigational drug to see if it reduces GERD symptoms in people who get only partial relief with their current medication.
The research site is in Chandler, Ariz.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/gerd.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
